Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease.

Bibliographic Collection: 
MOCA Reference, APE
Publication Type: Journal Article
Authors: Johnson, R.; Richter, N.; Jauch, R.; Gaughwin, P. M.; Zuccato, C.; Cattaneo, E.; Stanton, L. W.
Year of Publication: 2010
Journal: Physiol Genomics
Volume: 41
Issue: 3
Pagination: 269-74
Date Published: 2010 May
Publication Language: eng
ISSN: 1531-2267
Keywords: 3T3 Cells, Animals, Base Sequence, HEK293 Cells, HeLa Cells, Humans, Huntington Disease, Mice, Molecular Sequence Data, Repressor Proteins, RNA, Messenger, RNA, Untranslated

In the neurons of Huntington's disease (HD) patients, gene regulatory networks are disrupted by aberrant nuclear localization of the master transcriptional repressor REST. Emerging evidence suggests that, in addition to protein-coding genes, noncoding RNAs (ncRNAs) may also contribute to neurodegenerative processes. To discover ncRNAs that are involved in HD, we screened genome-wide data for novel, noncoding targets of REST. This identified human accelerated region 1 (HAR1), a rapidly evolving cis-antisense locus that is specifically transcribed in the nervous system. We show that REST is targeted to the HAR1 locus by specific DNA regulatory motifs, resulting in potent transcriptional repression. Consistent with other REST target genes, HAR1 levels are significantly lower in the striatum of HD patients compared with unaffected individuals. These data represent further evidence that noncoding gene expression changes accompany neurodegeneration in Huntington's disease.

DOI: 10.1152/physiolgenomics.00019.2010
Alternate Journal: Physiol. Genomics
Related MOCA Topics: